These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 32211357)
1. Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis: A Case Report and Literature Review. Jiang H; Yang Z Front Pediatr; 2020; 8():93. PubMed ID: 32211357 [TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease. Kang HR; Kwon YH; Yoo ES; Ryu KH; Kim JY; Kim HS; Kim HM; Lee YH Blood Res; 2013 Dec; 48(4):254-7. PubMed ID: 24466549 [TBL] [Abstract][Full Text] [Related]
3. The History of Macrophage Activation Syndrome in Autoimmune Diseases. Silverman ED Adv Exp Med Biol; 2024; 1448():21-31. PubMed ID: 39117805 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease. Dong S; Bout-Tabaku S; Texter K; Jaggi P J Pediatr; 2015 May; 166(5):1283-8. PubMed ID: 25771391 [TBL] [Abstract][Full Text] [Related]
5. [Eperythrozoonosis complicated with hemophagocytic syndrome: report of four cases and review of literature]. Li JG; Zhang D; Zhou ZX; Li SN; Kang M; Lai JM Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):303-307. PubMed ID: 29614573 [No Abstract] [Full Text] [Related]
6. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ. Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156 [TBL] [Abstract][Full Text] [Related]
7. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis. Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis. Horne A; von Bahr Greenwood T; Chiang SCC; Meeths M; Björklund C; Ekelund M; Erensjö P; Berg S; Hagelberg S; Bryceson YT; Andersson U; Henter JI J Rheumatol; 2021 Oct; 48(10):1596-1602. PubMed ID: 33589555 [TBL] [Abstract][Full Text] [Related]
9. Secondary hemophagocytic lymphohistiocytosis associated with Rocky Mountain spotted fever in a toddler: A case report. Hosahalli Vasanna S; Lim PPC; Khan TS; Dalal J EJHaem; 2022 May; 3(2):463-466. PubMed ID: 35846066 [TBL] [Abstract][Full Text] [Related]
10. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review. Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645 [TBL] [Abstract][Full Text] [Related]
11. Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis. Orth HM; Fuchs A; Lübke N; Jensen BO; Luedde T Virol J; 2022 Jun; 19(1):107. PubMed ID: 35752863 [TBL] [Abstract][Full Text] [Related]
12. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis. Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138 [TBL] [Abstract][Full Text] [Related]
13. Prolonged Fever in a Pediatric Patient: A Case of Systemic Juvenile Idiopathic Arthritis (sJIA) Complicated by Macrophage Activation Syndrome (MAS). Cortes M; Nudelman BG; Rouse MJ; Frost MD Cureus; 2023 Sep; 15(9):e46083. PubMed ID: 37900539 [TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis. Brossard P; Laveille C Rheumatol Ther; 2024 Jun; 11(3):869-880. PubMed ID: 38662147 [TBL] [Abstract][Full Text] [Related]
15. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis. Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800 [TBL] [Abstract][Full Text] [Related]
16. Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide. Choi JE; Kwak Y; Huh JW; Yoo ES; Ryu KH; Sohn S; Hong YM Korean J Pediatr; 2018 May; 61(5):167-173. PubMed ID: 29853942 [TBL] [Abstract][Full Text] [Related]
17. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome. Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063 [TBL] [Abstract][Full Text] [Related]
18. Macrophage activation syndrome: early diagnosis is key. Lerkvaleekul B; Vilaiyuk S Open Access Rheumatol; 2018; 10():117-128. PubMed ID: 30214327 [TBL] [Abstract][Full Text] [Related]
19. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome and coronary artery dilatation misdiagnosed as Kawasaki disease. Keskindemirci G; Aktay Ayaz N; Melikoğlu N; Bornaun H; Aydoğmuş Ç; Aldemir E; Aydoğan G Turk J Pediatr; 2015; 57(5):518-21. PubMed ID: 27411422 [TBL] [Abstract][Full Text] [Related]
20. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis. Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]